Browsing by Subject "Middle East Respiratory Syndrome Coronavirus"
Now showing items 1-20 of 27
-
Acurácia dos testes diagnósticos registrados na Anvisa para a COVID-19 (maio de 2020)
(2020-05)Assunto: acurácia dos testes diagnósticos para a COVID-19 registrados na Anvisa. -
The anticoagulant nafamostat potently inhibits SARS-CoV-2 infection in vitro: an existing drug with multiple possible therapeutic effects
(2020-04-23)Although infection by SARS-CoV-2, the causative agent of COVID-19, is spreading rapidly worldwide, no drug has been shown to be sufficiently effective for treating COVID-19. We previously found that nafamostat mesylate, ... -
Considerações sobre a investigação de casos e aglomerados de casos (clusters) da COVID-19: orientação provisória (13 de março de 2020)
(2020-03-13)[Introdução]: Este documento apresenta uma orientação provisória aos Estados Membros para uma rápida investigação de casos suspeitos de COVID-19 após um alerta ou sinal. Tem como propósito ser utilizada por autoridades de ... -
Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
(2020-03-23)The current coronavirus disease 2019 (COVID-19) pneumonia pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading globally at an accelerated rate, with a basic reproduction number ... -
Coronavirus disease 2019: a clinical review
(2020)In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, and it subsequently spread in many countries around ... -
Coronavirus in Pregnancy and Delivery: Rapid Review and Expert Consensus
(2020-03-08)BACKGROUND Person to person spread of COIVD-19 in the UK has now been confirmed. There are limited case series reporting the impact on women affected by coronaviruses (CoV) during pregnancy. In women affected by SARS and ... -
Effectiveness of Intravenous Immunoglobulin for Children with Severe COVID-19: A Rapid Review
(2020-04-22)Background: Intravenous immunoglobulin (IVIG) is usually used as supportive therapy, but the treatment of COVID-19 by IVIG is controversial. This rapid review aims to explore the clinical effectiveness and safety of IVIG ... -
Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis
(2020-04-30)The rapidly progressing of coronavirus disease 2019 (COVID-19) pandemic has become a global concern. This meta-analysis aimed at evaluating the efficacy and safety of current option of therapies for severe acute respiratory ... -
Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis
(2020-06-25)Background: There is no vaccine or specific antiviral treatment for HCoVs infection. The use of type I interferons for coronavirus is still under great debate in clinical practice. Materials and methods: A literature search ... -
Exames laboratoriais para a doença causada pelo novo coronavírus (COVID-19) de casos suspeitos em humanos: orientações provisórias (19 Março 2020)
(2020-03-19)[Introdução]: Este documento apresenta uma orientação provisória aos laboratórios e diferentes atores envolvidos na realização de exames laboratoriais para o vírus COVID-19. Ele baseia-se parcialmente na orientação provisória ... -
Higher mortality in men from COVID19 infection-understanding the factors that drive the differences between the biological sexes
(2020-04-24)The emergent global pandemic caused by the rapid spread of Severe Acute Respiratory syndrome- Coronavirus-2 (SARS-CoV-2) has led to increased mortality and negatively impacted day to day activities of humankind within a ... -
Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis
(2020-10-01)Background: Health care workers (HCW) are at high risk of developing physical/mental health outcomes related to coronavirus syndromes. Nature and frequency of these outcomes are undetermined. Methods: PRISMA/MOOSE-compliant ... -
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
(2020-05-05)We performed a meta-analysis to determine safety and efficacy of corticosteroids in SARS-CoV-2, SARS-CoV, and MERS-CoV infections. We searched PubMed, Web of Science, Medline, WanFang Chinese database, and ZhiWang Chinese ... -
Long-term clinical outcomes in survivors of coronavirus outbreaks after hospitalization or ICU admission: a systematic review and meta-analysis of follow-u studies
(2020-04-22)Objective: To determine the long-term clinical problems in adult survivors of coronavirus (CoV) infection [Coronavirus disease 2019 (COVID-19), Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome ... -
Long-term clinical outcomes in survivors of SARS and MERS
(2020-07-20)Citation: Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: ... -
Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS
(2020-04-08)The purpose of this paper is to reveal the spread rules of the three pneumonia: COVID-19, SARS and MERS. We compare the new spread characteristics of COVID-19 with those of SARS and MERS. By considering the growth rate and ... -
MERS-CoV as an emerging respiratory illness: A review of prevention methods
(2019-12)Introduction: Middle East Respiratory Coronavirus Virus (MERS-CoV) first emerged from Saudi Arabia in 2012 and has since been recognized as a significant human respiratory pathogen on a global level. Methods: In this ... -
Neurological associations of COVID-19
(2020-07-02)Background: The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with ... -
Potential Effects of Coronaviruses on the Cardiovascular System: A Review
(2020-03-27)Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19) has reached a pandemic level. Coronaviruses are known to affect the cardiovascular system. We review ... -
Prevalence of Diabetes Mellitus and Its Associated Unfavorable Outcomes in Patients With Acute Respiratory Syndromes Due to Coronaviruses Infection: A Systematic Review and Meta-Analysis
(2020-10-19)Introduction: Only 3 types of coronavirus cause aggressive respiratory disease in humans (MERS-Cov, SARS-Cov-1, and SARS-Cov-2). It has been reported higher infection rates and severe manifestations (ICU admission, need ...